Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8

Petr Widimský(Charles University), Michael Aschermann, Stanislav Simek(Charles University), Marek Malý(National Institute of Public Health), Roman Miklík(Masaryk University), Martin Poloczek(Masaryk University), Dana Bilkova(Charles University), Petr Kala(Masaryk University), Petr Kuchynka(Charles University), Zuzana Moťovská(Charles University), Radek Pudil(Charles University), Hana Skalická(University of Iowa), F Holm(Technical University of Liberec), Robért Petr(Charles University)
European Heart Journal
January 3, 2008
10.1093/eurheartj/ehn169
Cited by 146

Related Papers

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674
Intravenous Platelet Blockade with Cangrelor during PCI
|New England Journal of Medicine|2009|643